We recently spoke with Satish Grampurohit, Co-founder and CEO, Cogniquest Technologies, Bengaluru, India. Cogniquest is a provider of an AI-enabled platform that powers Intelligent Document Processing (IDP). The Cogniquest AI Platform helps businesses reduce the time employees spend on manual data collection and empowers them to focus on more critical tasks. To learn more about
OIG Reports that Clinical Trials Lack Diverse Subjects: What Role Can Artificial Intelligence Play?
As the largest public funder of biomedical research in the world, the National Institutes of Health (“NIH”) annually funds over $38 billion in extramural research, including about $6 billion for clinical trials. On May 28, 2024, OIG published a report (“OIG Report”) summarizing its finding that, of the NIH‑funded clinical trials randomly selected by OIG for review, a
The Overturning of Chevron Deference: Implications for AI in Medical Research
In a landmark decision on June 28, 2024, the Supreme Court overturned a 40-year-old legal precedent known as Chevron deference. Established in 1984, Chevron deference mandated that judges defer to federal agencies concerning interpretations of ambiguous laws, as long as those interpretations were reasonable. This doctrine has been a cornerstone of administrative law, significantly impacting
HR, Accounting, Finance and AI in Medical Practices, With Erik Miller of MedHQ
The back office of a medical practice is like the offensive line on a football team: It does the job no one else wants to do.
On this episode of The Corner Series, host Geoff Cockrell is joined by MedHQ President Erik Miller to discuss how outside back-office support for areas such as
Assessing Data Assets in Healthcare: A Discussion with Arti Bedi Pullins
Gradually, data is being recognized as an asset in an increasingly data-hungry healthcare industry. In the tenth episode of Sheppard Mullin’s Health-e Law Podcast, Arti Bedi Pullins, President and Chief Healthcare Officer at QuestionPro, discusses how industry players can recognize the value of data as an asset with Sheppard Mullin’s Digital Health Team co-chairs, Sara
Healthcare & Life Sciences Private Equity Deal Tracker: SAIGroup Acquires Get Well
SAIGroup has announced it has acquired Get Well.
Get Well, founded in 2000 and based in Bethesda, Maryland, is a provider of patient engagement technology and services.
SAIGroup, founded in 2017 and based in Palo Alto, California, is a private equity firm focused on acquiring and growing enterprise artificial intelligence companies that operate in
FDA Announces Workshop on AI Used In Drug & Biological Product Development
FDA recently announced that it will host a public workshop on August 6, 2024 focused on “Artificial Intelligence (AI) in Drug & Biological Product Development.” Aimed at bringing drug sponsors and AI experts together, the workshop, hosted in collaboration with the Clinical Trials Transformation Initiative, will feature presentations and a panel discussion around guiding principles
Updated NIST Guidelines Aim to Simplify Data Protection for Federal Contractors
Contractors that do business with the federal government must adhere to specific guidelines for safeguarding sensitive information. The National Institute of Standards and Technology (NIST) issues and revises those guidelines. The guidelines ensure that controlled unclassified information (CUI) is adequately protected. Recently, NIST has updated these guidelines to enhance clarity and usability.
What is Controlled
Virtual and Digital Health Digest – June 2024
This digest covers key virtual and digital health regulatory and public policy developments during May and early June 2024 from United Kingdom, and European Union.
Of interest, artificial intelligence (AI) safety has been in focus over the past month, including with the publication of the Interim International Scientific Report on the Safety of Advanced AI.
Au royaume des idées, les faits n’ont pas d’importance
« Débâcle : Changement fâcheux qui emporte la fortune d’un particulier, la prospérité d’un gouvernement, les opinions, les mœurs, comme la débâcle emporte les glaces de la rivière » (Littré). Emmanuel Goldorak n’aime pas subir : « Action-Transformation-Dissolution ». Tout le monde veut une rupture, du changement, des mesures fortes,